ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01569295
Brief Title: A Randomized, Double-Blind and Placebo-Controlled Study of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela)

First Submitted : March 27, 2012
First Submitted that Met QC Criteria : March 30, 2012
First Posted : April 3, 2012 (Estimate)

Results First Submitted : December 18, 2017
Results First Submitted that Met QC Criteria : January 29, 2018
Results First Posted : February 27, 2018

Certification/Extension First Submitted : May 24, 2016
Certification/Extension First Submitted that Met QC Criteria : May 24, 2016
Certification/Extension First Posted : June 6, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 7, 2019
Last Update Posted : January 16, 2019